Bayer AG and Perfuse Therapeutics Inc. have announced an agreement under which Bayer will fully acquire Perfuse Therapeutics, ...

R. Jude Samulski, Ph.D., was honored by the American Society of Gene + Cell Therapy (ASGCT) with its Founders Award at the ...

North Carolina Agricultural and Technical State University will collaborate with another historically Black college and ...

Durham-based BioCryst Pharmaceuticals, a global biotechnology company focused on developing and commercializing medicines for rare diseases, has signed a European licensing agreement for one of its ...

The Alexandria Center for Life Science - Durham North Campus (ACLS-D), at 42 Moore Drive, won the distinction. It’s located ...

Novartis announced a second investment in NC of $220M for a new facility on its Morrisville campus, focused on active pharmaceutical ingredient API manufacturing for solid dosage tablets, capsules, ...

The North Carolina Research Administrators Alliance (NC RAA) is an all-volunteer network that fosters collaboration, professional growth, and knowledge sharing among research administrators statewide.

Fresh off a new funding round, Durham startup Ten63 Therapeutics is looking to advance its technology platform that uses artificial intelligence to unlock discoveries for difficult-to-treat cancers.

Durham-based Priovant Therapeutics has announced positive results from its Phase 2 BEACON study evaluating brepocitinib in cutaneous sarcoidosis (CS). CS is an inflammatory granulomatous skin disease ...

A California medical technology startup plans to expand the Research Triangle Park facility it bought in 2022, adding 50 jobs and spending up to $65 million on the project. Science Corp. in Alameda, ...

Duke University spinout Tune Therapeutics is rehearsing the overture of its avant-garde therapeutic platform targeting chronic Hepatitis B Virus (HBV) that could also upend many more chronic disease ...